Search
Combined anticancer therapy with imidazoacridinone analogue C‐1305 and paclitaxel in human lung and colon cancer xenografts—Modulation of tumour angiogenesis
Abstract
The acridanone derivative 5-dimethylaminopropylamino- 8- hydroxytriazoloacridinone (C-1305) has been described as a potent inhibitor of cancer cell growth. Its mechanism of action in in vitro conditions was attributed, among others, to its ability to bind and stabilize the microtubule network and subsequently exhibit its tumour- suppressive effects in synergy with paclitaxel (PTX). Therefore, the objective of the present study was to analyse the effects of the combined treatment of C-1305 and PTX in vivo. In addition, considering the results of previous genomic analyses, par-ticular attention was given to the effects of this treatment on tumour angiogenesis. Treatment with C-1305 revealed antitumor effect in A549 lung cancer cells, and com-bined treatment with PTX showed tendency to anticancer activity in HCT116 colon cancer xenografts. It also improved tumour blood perfusion in both tumour models. The plasma level of CCL2 was increased and that of PDGF was decreased after com-bined treatment with C-1305 and PTX. The experimental results showed that the levels of FGF1, TGF-β and Ang-4 decreased, whereas the levels of ERK1/2 and Akt phosphorylation increased in HCT116 tumour tissue following combined treatment with both drugs. The results of in vitro capillary- like structure formation assay dem-onstrated the inhibiting effect of C-1305 on this process. Although previous in vitro and in vivo studies suggested a positive effect of C-1305 on cancer cells, combined treatment of HCT116 human colon and A549 lung cancer cells with both PTX and C- 1305 in vivo showed that the antitumor activity was restricted and associated with the modulation of tumour angiogenesis.
Citations
-
4
CrossRef
-
0
Web of Science
-
4
Scopus
Authors (11)
-
Marta Świtalska
-
Beata Filip‐Psurska
-
Magdalena Milczarek
-
Mateusz Psurski
-
Adrianna Moszyńska
-
Aleksandra Dąbrowska
-
Małgorzata Gawrońska
-
Karol Krzymiński
-
Rafał Bartoszewski
-
Joanna Wietrzyk
Cite as
Full text
- Publication version
- Accepted or Published Version
- DOI:
- Digital Object Identifier (open in new tab) 10.1111/jcmm.17430
- License
-
open in new tab
Keywords
Details
- Category:
- Articles
- Type:
- artykuły w czasopismach
- Published in:
-
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
no. 26,
pages 3950 - 3964,
ISSN: 1582-1838 - Language:
- English
- Publication year:
- 2022
- Bibliographic description:
- Świtalska M., Filip‐psurska B., Milczarek M., Psurski M., Moszyńska A., Dąbrowska A., Gawrońska M., Krzymiński K., Bagiński M., Bartoszewski R., Wietrzyk J.: Combined anticancer therapy with imidazoacridinone analogue C‐1305 and paclitaxel in human lung and colon cancer xenografts—Modulation of tumour angiogenesis// JOURNAL OF CELLULAR AND MOLECULAR MEDICINE -Vol. 26,iss. 14 (2022), s.3950-3964
- DOI:
- Digital Object Identifier (open in new tab) 10.1111/jcmm.17430
- Sources of funding:
- Verified by:
- Gdańsk University of Technology
seen 47 times
Recommended for you
Antiproliferative, Antiangiogenic, and Antimetastatic Therapy Response by Mangiferin in a Syngeneic Immunocompetent Colorectal Cancer Mouse Model Involves Changes in Mitochondrial Energy Metabolism
- C. J. Rodriguez-Gonzalez,
- I. Hernández-Balmaseda,
- K. Declerck
- + 12 authors
Quantum Dots as a Good Carriers of Unsymmetrical Bisacridines for Modulating Cellular Uptake and the Biological Response in Lung and Colon Cancer Cells
- J. Pilch,
- P. Kowalik,
- P. Bujak
- + 2 authors
In Vitro and In Vivo Imaging-Based Evaluation of Doxorubicin Anticancer Treatment in Combination with the Herbal Medicine Black Cohosh
- A. Płoska,
- M. Woźniak,
- J. Hedhli
- + 9 authors